XIAFLEX
These highlights do not include all the information needed to use XIAFLEX safely and effectively. See full prescribing information for XIAFLEX. XIAFLEX (collagenase clostridium histolyticum) for injection, for intralesional use Initial U.S. Approval: 2010
Approved
Approval ID
805cecd0-fd1f-11dd-87af-0800200c9a66
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 31, 2022
Manufacturers
FDA
Endo Pharmaceuticals Inc.
DUNS: 178074951
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
collagenase clostridium histolyticum
PRODUCT DETAILS
NDC Product Code66887-003
Application NumberBLA125338
Marketing CategoryC73585
Route of AdministrationN/A
Effective DateAugust 9, 2022
Generic Namecollagenase clostridium histolyticum